Conventional+Medication

[[image:conventional_medication_banner.jpg width="800" height="119"]]
== = = = = = =

Such drugs include oseltamivir (Tamiflu®)....

 * [[image:tamiflu_molecule.gif width="287" height="245" align="left" caption="Figure 2. The molecular structure of oseltamivir"]] || [[image:tamiflu1_box_&_pill.jpg width="461" height="254" align="right" caption="Figure 3. Tamiflu - packaging"]] ||

......and zanamivir (Relenza®)....

 * [[image:zanamivir_molecule.jpg width="318" height="246" align="left" caption="Figure 4. The molecular structure of zanamivir"]] || [[image:Relenza%20rotadisk_26117_packaging.gif width="391" height="245" align="right" caption="Figure 5. Relenza - packaging"]] ||

These include medications from drugs such as rimantadine (Flumadine®) and amantadine (Symmetrel®).

 * [[image:influenzavirus/rimantadine_molecule.gif width="221" height="204" align="center" caption="Figure 6. The molecular structure of rimantadine"]]

= = || ||

= = ||
 * [[image:influenzavirus/amantadine_structure.jpg width="215" height="157" align="center" caption="Figure 10. The molecular structure of amantadine"]] || [[image:influenzavirus/symmetrel_tablet.jpg width="174" height="97" align="center" caption="Figure 11. Symmetrel tablet"]]

|| ||

====Unfortunately, Global stock of NA inhibitor medication is estimated to be sufficient to treat only 5% of the world’s population were a pandemic to occur (Rasmussen). On another note, the viruses continually mutate and become resistant to current medications. Modern medicine is continuously developing new drugs to fight resistant viral strains.====

[[image:reference_bar_final.jpg width="800" height="43" link="References"]]
__Figures:__ Figure 1. Neuraminidae inhibition. Image Source Page: @http://www.chm.bris.ac.uk/motm/tamiflu/how_work.htm Figure 2. The molecular structure of oseltamivir. Image Source Page: @http://www-jmg.ch.cam.ac.uk/data/molecules/misc/tamiflu.html Figure 3. Tamiflu - packaging. Image Source Page: @http://www.bolsonweb.com.ar/diariobolson/detalle.php?id_noticia=22502 Figure 4. The molecular structure of zanamivir. Image Source Page: @http://chemistry.about.com/od/factsstructures/ig/Chemical-Structures---R/Relenza.htm Figure 5. Relenza - packaging. Image Source Page: @http://www.mims.com/Singapore/drug/info/Relenza/Relenza%20rotadisk Figure 6. The molecular structure of rimantadine. Image Source Page: @http://www.pharmacopeia.cn/v29240/usp29nf24s0_m73680.html Figure 7. Flumadine tablet. Image Source Page: @http://www.medhelp.org/tags/show/119417/Flumadine Figure 8. Flumadine - packaging. Image Source Page: @http://www.drugs.com/pro/flumadine.html Figure 9. Flumadine syrup. Image Source Page: @http://www.drug3k.com/imagepages/10542/image4.html Figure 10. The molecular structure of amantadine. Image Source Page: @http://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=10445 Figure 11. Symmetrel tablet. Image Source Page: @http://www.drug3k.com/drug/Symmetrel-12023.htm Figure 12. Symmetrel - packaging. Image Source Page: @http://www.medicalook.com/a-z/S.html Figure 13. Symmetrel syrup. Image Source Page: @http://epda.eu.com/medinfo/amantadine/